Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Hossein Ali Shahriari"'
Autor:
Homayoun Nikkhah, Saeed Karimi, Hamid Ahmadieh, Mohsen Azarmina, Majid Abrishami, Hossein Ahoor, Yousef Alizadeh, Hasan Behboudi, Narsis Daftarian, Mohammad Hossein Dehghan, Morteza Entezari, Fereydoun Farrahi, Heshmatollah Ghanbari, Khalil Ghasemi Falavarjani, Mohammad Ali Javadi, Reza Karkhaneh, Siamak Moradian, Masoud Reza Manaviat, Morsal Mehryar, Ramin Nourinia, Mohammad Mehdi Parvaresh, Alireza Ramezani, Alireza Ragati Haghi, Mohammad Riazi-Esfahani, Masoud Soheilian, Mohsen Shahsavari, Hossein-Ali Shahriari, Zhale Rajavi, Sare Safi, Armin Shirvani, Saeed Rahmani, Hamideh Sabbaghi, Mojgan Pakbin, Bahareh Kheiri, Hossein Ziaei
Publikováno v:
Journal of Ophthalmic & Vision Research, Vol 13, Iss 2, Pp 158-169 (2018)
Purpose: To provide the clinical recommendations for the administration of intravitreal anti-vascular endothelial growth factor (VEGF) drugs especially bavacizumab for ocular vascular diseases including diabetic macular edema, neovascular age-related
Externí odkaz:
https://doaj.org/article/692686368bc64b168728515c3ce1dbdf
The First Inherited Retinal Disease Registry in Iran: Research Protocol and Results of a Pilot Study
Autor:
Laleh Pazooki, Mahtab Salami, Thomas Haaf, Shahnaz Mojarrab, Proshat Saviz, Fatemeh Suri, masoumeh kalantarion, Sina Madani, Houra Naraghi, Frans P.M. Cremers, Hamideh Sabbaghi, Elham Sabbaghi, Paulina Bahena-Carbajal, Mehdi Yaseri, Barbara Vona, Afrooz Moghadasi, Narsis Daftarian, Mehraban Mirrahimi, Abbas Sheikhtaheri, Hossein Ali Shahriari, Ali Reza Maleki, Kazem Zendedel, Bahareh Kheiri, Farid Khorrami, Monireh Sargazi, Seyed Sajad Ahmadi, Ali Tivay, Maryam Najafi, Hamid Ahmadieh, Mohammad Zarei Nejad
Publikováno v:
Archives of Iranian Medicine, 23, 7, pp. 445-454
Archives of Iranian Medicine, 23, 445-454
Archives of Iranian Medicine, 23, 445-454
Background: To describe the protocol for developing a national inherited retinal disease (IRD) registry in Iran and present its initial report. Methods: This community-based participatory research was approved by the Ministry of Health and Medical Ed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3694aa2154516267126b08052a907785
https://hdl.handle.net/2066/221586
https://hdl.handle.net/2066/221586
Autor:
Khalil Ghasemi Falavarjani, Hasan Behboudi, Saeed Karimi, Homayoun Nikkhah, Armin Shirvani, Mohammad Hossein Dehghan, Mohsen Shahsavari, Mojgan Pakbin, Hamideh Sabbaghi, Zhale Rajavi, Morteza Entezari, Mohammad Mehdi Parvaresh, Ramin Nourinia, Yousef Alizadeh, Hossein-Ali Shahriari, Bahareh Kheiri, Sare Safi, Fereydoun Farrahi, Alireza Ragati Haghi, Mohammad Ali Javadi, Hamid Ahmadieh, Masoud Reza Manaviat, Mohsen Azarmina, Hossein Ziaei, Alireza Ramezani, Siamak Moradian, Narsis Daftarian, Morsal Mehryar, Saeed Rahmani, Masoud Soheilian, Reza Karkhaneh, Majid Abrishami, Mohammad Riazi-Esfahani, Heshmatollah Ghanbari, Hossein Ahoor
Publikováno v:
Journal of Ophthalmic & Vision Research
Journal of Ophthalmic & Vision Research, Vol 13, Iss 2, Pp 158-169 (2018)
Journal of Ophthalmic & Vision Research, Vol 13, Iss 2, Pp 158-169 (2018)
Purpose: To provide the clinical recommendations for the administration of intravitreal anti-vascular endothelial growth factor (VEGF) drugs especially bavacizumab for ocular vascular diseases including diabetic macular edema, neovascular age-related
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5b88220c5bfeb257563001bda859bb19
https://pubmed.ncbi.nlm.nih.gov/29719645
https://pubmed.ncbi.nlm.nih.gov/29719645